PATENT CLAIM ANALYSIS

Application Number: 16280356
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "278100"]

Abstract:
The present invention provides formulations that support an individual's body during routine vaccination and adaptive immune response. The individuals who can benefit from these formulations are infants, children and adults. The formulations comprise ingredients that can be administered prior to, concurrent with or subsequent to the vaccination. The formulations of the present invention preferably act by targeting enzymatic reactions an individual's various metabolic pathways, maintaining balance between oxidative stress and methylation, maintaining balance between Th1 and Th2 responses, or a combination thereof during vaccination and adaptive immune response.

Claim (Index 10):
The method of  claim 1 , wherein biologic biomarkers may be measured and assessed through blood, serum or plasma samples, before, during and after formulation administration, to determine the effectiveness of said formulation on supporting an individual's body during vaccination, an individual's immune system function and adaptive immunity.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.57143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15226415', '14662143', '12080189', '12157077', '11943176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7392349852541424
- 35 USC 102 Novelty (BERT): 0.5480474862660779
- Combined Prediction Score: 0.720116235355336
- Mean Citation Score: 254.194662
- Max Citation Score: 440.54672
- Similarity Product: 247.9218075610352

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test